Evaluation of patients with Parkinson' s disease in terms of psychiatric diseases and related clinical features

Authors

  • Mustafa Akan Turgut Ozal University, Malatya Training and Research Hospital, Department of Psychiatry, Malatya, Türkiye
  • Suheyla Unal University of Health Sciences, Bursa High Specialization Training and Research Hospital, Department of Psychiatry, Bursa, Türkiye
  • Sibel Altinayar Private Egepol Hospital, Department of Neurology, Izmir, Türkiye
  • Lale Gonenir Erbay Inonu University, Faculty of Medicine, Department of Psychiatry, Malatya, Türkiye

Keywords:

Parkinson’ s disease, Anxiety, Depression, Dopamine, Serotonin

Abstract

Aim: In this article, we aimed to evaluate patients with Parkinson’ s disease (PD) in terms of psychiatric diseases and related clinical features.

Materials and Methods: 101 patients diagnosed with PD and 101 randomly selected control cases who applied to general internal medicine and endocrine outpatient clinics were included in the study. All subjects were administered a questionnaire including questions about their sociodemographic and clinical features, and were evaluated by the psychiatrist.

Results: The rate of psychiatric disease (42.6%) in the PD group was significantly higher than the control group. Anxiety disorders and depression were the most common among these diseases. Also the use of antidepressant in the PD group was higher than the control group.

Conclusion: Psychiatric disorders are seen more frequently in patients with PD than in patients with other physical diseases. Considering that quality of life in patients with PD is associated with psychiatric well-being, psychiatric symptoms in patients are of high clinical importance. The physician’ s awareness of psychiatric symptoms and taking necessary precautions will contribute positively to the treatment of the disease.

Downloads

Download data is not yet available.

Downloads

Published

2022-07-25

Issue

Section

Original Articles

How to Cite

1.
Evaluation of patients with Parkinson’ s disease in terms of psychiatric diseases and related clinical features. Ann Med Res [Internet]. 2022 Jul. 25 [cited 2025 Feb. 23];29(7):733-7. Available from: http://annalsmedres.org/index.php/aomr/article/view/4227